The remaining 6 studies including women with intrapartum cesarean sections investigated different doses or application schedules of exogenous oxytocin or compared oxytocin to other uteronotics after cesarean delivery for PPH prophylaxis [28–32]. The gene discussed is OXT; the disease is pulmonary arterial hypertension.